Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets
- PMID: 159312
- PMCID: PMC371272
- DOI: 10.1172/JCI109581
Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets
Abstract
Antibodies to T cells present in the plasma of patients with active systemic lupus erythematosus (SLE) plus complement are able to eliminate concanavalin A-induced suppressor function for the proliferative responses of T cells to allogeneic lymphocytes (MLR) and of B cells to pokeweed mitogen (PWM). Such antibodies were found to be effective in eliminating suppressor function only when T cells were treated before activation; there was no effect when treatment was performed after activation. These studies indicate that the antibodies preferentially interact with a T cell necessary for the generation of suppressor cells, rather than with mature, activated suppressor cells. Studies of individual SLE patients indicate that the same defects observed in SLE T cells were induced in normal T cells by plasma from that patient. Such observations suggest that many T-cell defects associated with active SLE may not be intrinsic T-cell abnormalities, but, rather, secondary effects of anti-T-cell antibodies. Studies of the T-cell subpopulations responsible for suppression of the MLR and PWM responses indicate that only T gamma cells (T cells bearing receptors for the Fc portion of immunoglobulin [Ig]G) acted as precursors of suppressor cells for the MLR, whereas both T gamma and T non-gamma cells (T cells not bearing receptors for the Fc portion of IgG) could be activated to suppress the PWM response. Consistent with this observation, SLE anti-T-cell antibodies that preferentially killed T gamma cells preferentially eliminated suppressor cells for the MLR.
Similar articles
-
Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.J Clin Invest. 1979 May;63(5):954-65. doi: 10.1172/JCI109396. J Clin Invest. 1979. PMID: 312810 Free PMC article.
-
Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.J Immunol. 1983 Apr;130(4):1706-12. J Immunol. 1983. PMID: 6220065
-
Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.J Clin Invest. 1980 Feb;65(2):519-28. doi: 10.1172/JCI109696. J Clin Invest. 1980. PMID: 6444308 Free PMC article.
-
Anti-lymphocyte antibodies in systemic lupus erythematosus.Clin Rheum Dis. 1985 Dec;11(3):523-49. Clin Rheum Dis. 1985. PMID: 3907954 Review.
-
The busy life of regulatory T cells in systemic lupus erythematosus.Discov Med. 2009 Jun;8(40):13-7. Discov Med. 2009. PMID: 19772836 Review.
Cited by
-
Inhibition of proliferative and suppressor responses in the autologous mixed lymphocyte reaction by serum from patients with systemic lupus erythematosus.Ann Rheum Dis. 1982 Oct;41(5):495-501. doi: 10.1136/ard.41.5.495. Ann Rheum Dis. 1982. PMID: 6215003 Free PMC article.
-
Production of anti-basement membrane-zone antibody by peripheral blood leukocytes of pemphigoid patients.J Clin Immunol. 1982 Jul;2(3):179-85. doi: 10.1007/BF00915220. J Clin Immunol. 1982. PMID: 6811607
-
Inhibition of soluble antigen-induced T cell proliferation by warm-reactive antibodies to activated T cells in systemic lupus erythematosus.J Clin Invest. 1984 Dec;74(6):1948-60. doi: 10.1172/JCI111615. J Clin Invest. 1984. PMID: 6210306 Free PMC article.
-
Autoantibodies against CD80 in patients with COPD.Clin Transl Immunology. 2016 Oct 7;5(10):e103. doi: 10.1038/cti.2016.57. eCollection 2016 Oct. Clin Transl Immunology. 2016. PMID: 27867516 Free PMC article.
-
Specific suppression of anti-DNA production in vitro.J Clin Immunol. 1988 Sep;8(5):362-71. doi: 10.1007/BF00917152. J Clin Immunol. 1988. PMID: 2460488
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources